Log In
BCIQ
Print this Print this
 

ATG-Fresenius S

  Manage Alerts
Collapse Summary General Information
Company Fresenius SE & Co. KGaA
DescriptionPolyclonal antibody preparation for T lymphocyte suppression
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/15/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today